Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHunting Regulatory News (HTG)

Share Price Information for Hunting (HTG)

Share Price is delayed by 15 minutes
Get Live Data
462.00    -15.50 (-3.25%)
Bid:
462.50
Ask:
463.50
Spread: 1.00 (0.216%)
Market Cap: £674.09m
HTG Live PriceLast checked at - London Stock Exchange

Intraday Hunting Share Chart

Equity Development Investor Presentation

19 Feb 2026 07:00

RNS Number : 5571T
Hunting PLC
19 February 2026
 

For Immediate Release

19 February 2026

 

 

 

Hunting PLC

 

("Hunting" or "the Company" or "the Group")

 

INVESTOR PRESENTATION ON 9 MARCH

 

 

Hunting will be giving an investor presentation hosted by Equity Development covering its FY2025 results for the financial year ending 31 December 2025.

 

The online event will take place at 2pm on Monday 9th March with Jim Johnson (Chief Executive) and Bruce Ferguson (Finance Director) presenting from the Company.

 

Hunting PLC (LSE: HTG) is a global engineering group that provides precision- manufactured equipment and premium services which add value to its clients.

 

The webinar is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end, or can be sent before the event to info@equitydevelopment.co.uk

 

To attend the webinar, please register to via the following link:

 

Register Here

 

For further information please contact:

 

Hunting PLC

Jim Johnson, Chief Executive

Bruce Ferguson, Finance Director

 

Tel: +44 (0) 20 7321 0123

Sodali & Co

James White

Tilly Abraham

Tel: +44 (0) 78 5543 2699

 

or

 

lon.IR@hunting-intl.com

 

About Hunting PLC

 

Hunting is a global, precision engineering group that provides precision-manufactured equipment and premium services, which add value for our customers. Established in 1874, it is a listed public company, quoted on the London Stock Exchange in the Equity Shares in Commercial Companies ("ESCC") category. The Company maintains a corporate office in Houston and is headquartered in London. As well as the United Kingdom, the Company has operations in China, India, Indonesia, Mexico, Saudi Arabia, Singapore, United Arab Emirates and the United States of America.

 

The Group reports in US dollars across five operating segments: Hunting Titan; North America; Subsea Technologies; Europe, Middle East and Africa ("EMEA"); and Asia Pacific.

 

The Group also reports revenue and EBITDA financial metrics based on five product groups: OCTG; Perforating Systems; Subsea; Advanced Manufacturing; and Other Manufacturing.

 

Hunting PLC's Legal Entity Identifier is 2138008S5FL78ITZRN66

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAAKFBBABKDFBD
Date   Source Headline
5th Mar 20264:32 pmRNSStandard form for notification of major holdings
5th Mar 20267:05 amRNSTransaction in Own Shares
5th Mar 20267:02 amRNSCost Reduction Plan & Update to Capital Allocation
5th Mar 20267:00 amRNSResults for the year ended 31 December 2025
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:05 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSNotification of major holdings
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
19th Feb 20267:00 amRNS-REquity Development Investor Presentation
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:05 amRNSOrganic Oil Recovery Pilot Test Result
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 202612:34 pmRNSStandard form for notification of major holdings
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNS2025 Full Year Trading Statement
12th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.